Monthly Archives: January 2018
P123 THE TRANS-GOLGI NETWORK PROTEIN AFTIPHILIN MAINTAINS COLONIC EPITHELIAL PERMEABILITY AND MUCOSAL INTEGRITY THROUGH BETA CATENIN DURING INFLAMMATION
Barrier function of colonic epithelium is compromised in IBD patients and contributes to colonic inflammation. Previously, we showed that aftiphilin (AFTPH) is significantly downregulated in colonic biopsies from UC patients and involved in receptor re… Continue reading
15 DISRUPTION OF FOXP3-EZH2 INTERACTION BY GENETIC MUTATION OR SIGNALING-INDUCED INACTIVATION REPRESENTS A NOVEL PATHOBIOLOGICAL MECHANISM IN INFLAMMATORY BOWEL DISEASE
While FOXP3+ regulatory T cell (Treg) dysfunction has been linked to human inflammatory bowel disease (IBD), molecular mechanisms for disease pathophysiology are unclear. The transcription factor FOXP3 via histone methyltransferase EZH2 suppresses infl… Continue reading
P027 DIFFERENTIAL BINDING OF RBPJ AND CUX1 TO IBD CAUSAL SNP RS1887428 MODIFIES EXPRESSION OF JAK2
Recently, genetic variants conferring risk for IBD were fine-mapped to single variant resolution. Eight of these causal variants resulted in amino acid substitutions while ten were non-coding. The mechanism by which these non-coding causal variants con… Continue reading
P115 THE IBD CANDIDATE GENE, PTPN2, RESTRICTS INTESTINAL BARRIER DEFECTS AND CLAUDIN-2 EXPRESSION VIA STAT INHIBITION
Loss-of-function mutations in the protein tyrosine phosphatase non-receptor type 2 (PTPN2) gene locus increase IBD susceptibility. We reported that PTPN2 knockdown (PTPN2-KD) in intestinal epithelial cells (IECs): (i) increased IFN-g activation of STAT… Continue reading
P026 DEVELOPMENT OF A PREFERENCE-WEIGHTED SYMPTOM SCALE FOR INFLAMMATORY BOWEL DISEASE
Practicing patient-centric care by incorporating patient preferences in IBD care is increasingly recognized to be important. However, existing IBD disease activity measures do not incorporate patient perspective. Here, we describe the development of a … Continue reading
P111 STRICTURING CROHN’S DISEASE OR A COMPLICATED MECKEL’S DIVERTICULUM WITH SMALL BOWEL STRICTURE?
Distinguishing between inflamed Meckel’s diverticulum (MD) and ileal Crohn’s disease (CD) can be challenging. We present a case of suspected MD in a patient with CD. Continue reading
P025 CYSTATHIONINE-GAMMA-LYASE REGULATES MACROPHAGE INTERLEUKIN-10 (IL-10) PRODUCTION IN COLITIS
Cystathionine-β-synthase (CBS) & cystathionine-γ-lyase (CSE), convert homocysteine into cysteine & produce H2S, an anti-inflammatory mediator. In rodent colitis models, CBS & CSE activity is elevated and inhibition or knockout of CSE worsens colitis & decreases levels of anti-inflammatory cytokine IL-10. IL-10 KO mice develop spontaneous colitis accompanied by homocysteinemia & decreased H2S production, which are reversed by IL-10 administration. However, the cellular source of CSE-dependent IL-10 production is unknown. Continue reading
P107 SINGLE-NUCLEOTIDE POLYMORPHISMS AT THE TNFAIP3 (A20) LOCUS IN HISPANIC PATIENTS ALTER TNFA SIGNALING
A20 (TNFAIP3) suppresses inflammation by interrupting the NF-kB pathway via its ubiquitin-editing activities. Several single-nucleotide polymorphisms (SNPs) have been shown to be associated with various autoimmune and inflammatory diseases, including IBD. Two such SNPs are rs146534657 (A305G) and rs2230926 (T380G) have minor allele frequencies of 0.1-1.3% and 6.1-17.9%, respectively. We investigate the frequencies of these SNPs in our majority (>60%) Hispanic population and explore their clinical impacts on IBD. Continue reading
P024 CROHN’S DISEASE MESSAGING ON TWITTER: WHO’S TALKING?
Twitter, a popular social networking service, enables users to interact with messages (tweets) limited to 140 characters. It is an increasingly powerful mechanism to convey information. There is limited data on the use of Twitter for disseminating medi… Continue reading